Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy.

Sebastian E Koschade Jan A StratmannBjörn SteffenShabnam ShaidFabian Finkelmeier Hubert Serve Wolfgang Miesbach Christian H Brandts Olivier Ballo

Published in: European journal of haematology (2023)

Early-onset VTE is a common complication in newly diagnosed AML patients admitted for induction chemotherapy. Leukocytosis is an independent VTE risk factor. The potentially adverse impact of non-CVC-related VTE merits further study.

Keyphrases

early onset
newly diagnosed
venous thromboembolism
acute myeloid leukemia
late onset
patients undergoing
locally advanced
risk factors
allogeneic hematopoietic stem cell transplantation
rectal cancer